Protective effects of baicalein against excess L-DOPA-induced dopamine quinone neurotoxicity

Neurological Research

Volumn 33, Issue 10, 2011, Pages 1050-1056

  Takeshima, Mika ^a,b   Murata, Maiko ^a   Urasoe, Natsuho ^a   Murakami, Shinki ^b   Miyazaki, Ikuko ^b   Asanuma, Masato ^b   Kita, Taizo ^a  

^a KYUSHU NUTRITION WELFARE UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Baicalein; Dopamine quinone; Dopamine induced neurotoxicity; Flavonoids; L DOPA

Indexed keywords

ANTIOXIDANT; BAICALEIN; DOPAMINE; FLAVONOID; GLUTATHIONE; LEVODOPA; QUINONE DERIVATIVE; RADICAL; REACTIVE OXYGEN METABOLITE; SEMIQUINONE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; CELL FREE SYSTEM; CELL VIABILITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ELECTRON SPIN RESONANCE; IN VITRO STUDY; LIPID PEROXIDATION; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; SPECTROMETER;

ANIMALS; ANTIOXIDANTS; ANTIPARKINSON AGENTS; CELL LINE; DOPAMINE; FLAVANONES; LEVODOPA; MICE; NEUROPROTECTIVE AGENTS; NEUROTOXINS;

EID: 84555203792     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132811Y.0000000032     Document Type: Article

References (34)

1. Asanuma M, Miyazaki I, Ogawa N. Dopamine-or L-DOPAinduced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease. Neurotox Res 2003;5:165-76
2. Metodiewa D, Koska C. Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurologic disorders. An overview. Neurotox Res 2000;1:197-233
3. Asanuma M, Miyazaki I, Diaz-Corrales FJ, Ogawa N. Quinone formation as dopaminergic neuron-specific oxidative stress in the pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism. Acta Med Okayama 2004;58:221-33
4. Graham DG. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 1978;14:633-43
5. Sulzer D, Zecca L. Intraneuronal dopamine-quinone synthesis: a review. Neurotox Res 2000;1:181-95
6. Kuhn DM, Arthur RE, Jr, Thomas DM, Elferink LA. Tyrosine hydroxylase is inactivated by catechol-quinones and convertedto a redox-cycling quinoprotein: possible relevance to Parkinson's disease. J Neurochem 1999;73:1309-17
7. LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ. Dopamine covalently modifies and functionally inactivates parkin. Nat Med 2005;11:1214-21
8. Whitehead RE, Ferrer JV, Javitch JA, Justice B. Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter. J Neurochem 2001;76:1242-51
9. Miyazaki I, Asanuma M. Approaches to prevent dopamine quinone-induced neurotoxicity. Neurochem Res 2009;34:698-706
10. Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52:673-751
11. Gao Z, Huang K, Yang X, Xu H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochim Biophys Acta 1999;1472:643-50
12. Hara H, Sukamoto T, Ohtaka H, Abe K, Tatumi Y, Saito Y, et al. Effects of baicalein and alpha-tocopherol on lipid peroxidation, free radical scavenging activity and 12-O-tetradecanoylphorbol acetate-induced ear edema. Eur J Pharmacol 1992;221:193-8
13. Hamada H, Hiramatsu M, Edamatsu R, Mori A. Free radical scavenging action of baicalein. Arch Biochem Biophys 1993;306:261-6
14. Huang WH, Lee AR, Yang CH. Antioxidative and antiinflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis GEORGI. Biosci Biotechnol Biochem 2006; 70:2371-80
15. Gao Z, Huang K, Xu H. Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in SH-SY5Y cells. Pharmacol Res 2001;43:173-8
16. Lebeau A, Esclaire F, Rostene W, Pelaprat D. Baicalein protects cortical neurons from beta-amyloid (25-35) induced toxicity. Neuroreport 2001;12:2199-202
17. Lee HH, Yang LL, Wang CC, Hu SY, Chang SF, Lee YH. Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate-and glucose deprivation-induced neuronal death. Brain Res 2003;986:103-13
18. Wu PH, Shen YC, Wang YH, Chi CW, Yen JC. Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum. Toxicology 2006;226:238-45
19. Im HI, Joo WS, Nam E, Lee ES, Hwang YJ, Kim YS. Baicalein prevents 6-hydroxydopamine-induced dopaminergic dysfunction and lipid peroxidation in mice. J Pharmacol Sci 2005;98:185-9
20. Lee HJ, Noh YH, Lee DY, Kim YS, Kim KY, Chung YH, et al. Baicalein attenuates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. Eur J Cell Biol 2005;84:897-905
21. Mu X, He G, Cheng Y, Li X, Xu B, Du G. Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro. Pharmacol Biochem Behav 2009;92:642-8
22. Cheng Y, He G, Mu X, Zhang T, Li X, Hu J, et al. Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile. Neurosci Lett 2008;441:16-20
23. Emdadul Haque M, Asanuma M, Higashi Y, Miyazaki I, Tanaka K, Ogawa N. Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells. Biochim Biophys Acta 2003;1619:39-52
24. Miyazaki I, Asanuma M, Diaz-Corrales FJ, Fukuda M, Kitaichi K, Miyoshi K, et al. Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules. FASEB J 2006;20:571-3
25. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969;27:502-22
26. Miyazaki I, Asanuma M, Diaz-Corrales FJ, Miyoshi K, Ogawa N. Dopamine agonist pergolide prevents levodopa-induced quinoprotein formation in parkinsonian striatum and shows quenching effects on dopamine-semiquinone generated in vitro. Clin Neuropharmacol 2005;28:155-60
27. Kita T, Miyazaki I, Asanuma M, Takeshima M, Wagner GC. Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity. Int Rev Neurobiol 2009;88:43-64
28. Chang WT, Shao ZH, Yin JJ, Mehendale S, Wang CZ, Qin Y, et al. Comparative effects of flavonoids on oxidant scavenging and ischemia-reperfusion injury in cardiomyocytes. Eur J Pharmacol 2007;566:58-66
29. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996;20:933-56
30. Pietta PG. Flavonoids as antioxidants. J Nat Prod 2000;63:1035-42
31. Lai CT, Yu PH. Dopamine-and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors. Biochem Pharmacol 1997;53:363-72
32. Ishige K, Schubert D, Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med 2001;30:433-46
33. Maher P, Salgado KF, Zivin JA, Lapchak PA. A novel approach to screening for new neuroprotective compounds for the treatment of stroke. Brain Res 2007;1173:117-25
34. Myhrstad MC, Carlsen H, Nordstrom O, Blomhoff R, Moskaug J. Flavonoids increase the intracellular glutathione level by transactivation of the gamma-glutamylcysteine synthetase catalytical subunit promoter. Free Radic Biol Med 2002;32:386-93